13 results
Colorectal Cancer Screening and Polyp Surveillance Intervals
Colon Cancer Screening - Modality - Interval:
 • Colonoscopy -
Colorectal Cancer ... Multitarget DNA stool test ... DeanEhrlich_MD #Colorectal ... Surveillance #Intervals #management ... #gastroenterology
Inherited Colorectal Cancer (CRS) Syndromes
Adenomatous Polyposis Syndromes:
 • Familial Adenomatous Polyposis (FAP), Attenuated FAP (AFAP), MUTYH
Inherited Colorectal ... Cancer (CRS) Syndromes ... #Cancer #CRS #Syndromes ... #diagnosis #management ... #gastroenterology
ACA Colorectal Cancer Screening Guidelines

When to Screen?
When to Stop?
Family History

Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based
ACA Colorectal Cancer ... Screening Guidelines ... Cancer Screening ... #table #management ... #gastroenterology
Primary sclerosing cholangitis (PSC) - Malignancy Screening and Surveillance Recommendations 

Cholangiocarcinoma 
 - Annual US or
) - Malignancy Screening ... Colonoscopy @ diagnosis ... PSC #Malignancy #Cancer ... #Gastroenterology ... #Management #Diagnosis
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
Characteristics for Colorectal ... Cancer Screening ... #Cancer #colon ... #Screening #Tests ... comparison #table #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Infections and Cervical Cancer ... Screening for Women ... Screening - Women ... or been newly diagnosed ... Prevention #Treatment #management
Colorectal Cancer screening in ulcerative colitis per new UC guidelines
- Colonoscopy is the recommended method for
Colorectal Cancer ... 8 years after diagnosis ... #Cancer #CRC #Colon ... #PrimaryCare #Gastroenterology ... #Management #Colonoscopy
What is Fecal Occult Blood Testing (FOBT)
 • Screening for colorectal cancer in average risk population
Testing (FOBT) • Screening ... for colorectal ... cancer in average ... immunochemical test ... Does not change management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... Tuberculosis Diagnosis ... Tuberculin skin test ... with TST or IGRA ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... Tuberculosis Diagnosis ... Tuberculin skin test ... with TST or IGRA ... #Diagnosis #Management